TAYSHA GENE THERAPIES INC shareholders Q3 2023

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 65 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

TAYSHA GENE THERAPIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,827,926$12,096,2468.11%
TCG Crossover Management, LLC 11,111,111$35,111,1115.17%
VR Adviser, LLC 14,444,444$45,644,4434.80%
Kynam Capital Management, LP 3,281,313$10,368,9491.70%
Ghost Tree Capital, LLC 1,325,000$4,187,0001.38%
Octagon Capital Advisors LP 2,777,778$8,777,7781.35%
RA Capital Management 18,472,503$58,373,1091.15%
RTW INVESTMENTS, LP 16,893,185$53,382,4651.13%
Diametric Capital, LP 760,014$2,401,6441.00%
Quantum Private Wealth, LLC 575,380$1,818,2010.87%
Sands Capital Ventures, LLC 724,873$2,290,5990.68%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 1,500,000$4,740,0000.66%
Artal Group S.A. 3,663,104$11,5750.50%
Eversept Partners, LP 1,705,774$5,390,2460.46%
EAM Investors, LLC 335,390$1,059,8320.20%
Avoro Capital Advisors LLC 3,925,000$12,403,0000.19%
Redwood Wealth Management Group, LLC 38,200$120,7120.14%
Alphabet Inc. 640,882$2,025,1870.13%
Polar Capital Holdings Plc 2,530,000$7,994,8000.06%
PRELUDE CAPITAL MANAGEMENT, LLC 240,251$759,1930.05%
External links

This page lists TAYSHA GENE THERAPIES INC's shareholders in Q3 2023. To view TAYSHA GENE THERAPIES INC's shareholder history, click here.